The United States-based specialty pharmaceutical company specializes in developing and commercializing novel, local therapies for musculoskeletal conditions, starting with osteoarthritis. Its flagship product, Zilretta, enhances the clinical effect of intra-articular corticosteroid treatment. Flexion shares risk and provides expertise to expand the portfolios of its partners. The biopharmaceutical company is headquartered in Burlington, Massachusetts.